Positron emission tomography/computed tomography (PET/CT) with68Ga-PSMA is a non-invasive diagnostic technique to image prostate cancer with increased prostate-specific membrane antigen (PSMA) expression. PSMA is a transmembrane protein present in all prostatic tissues. Increased PSMA expression is seen in several malignancies, although prostate cancer is the tumour where it presents higher concentrations. Almost all prostate adenocarcinomas show PSMA expression in most of lesions, primary and metastatic. Immunohistochemistry has demonstrated that the expression of PSMA increases in patients with de-differentiated, metastatic or hormone-refractory tumours. Moreover, the expression level of PSMA has a prognostic value for disease outcome. PET measures the three-dimensional distribution of68Ga-PSMA, producing semi-quantitative images that allow for non-invasive assessment of PSMA expression.

García Garzón, J., de Arcocha Torres, M., Delgado-Bolton, R., Ceci, F., Alvarez Ruiz, S., Orcajo Rincón, J., et al. (2018). 68Ga-PSMA PET/CT in prostate cancer. REVISTA ESPAÑOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 37(2), 130-138 [10.1016/j.remn.2017.07.004].

68Ga-PSMA PET/CT in prostate cancer

Ceci, F.;
2018

Abstract

Positron emission tomography/computed tomography (PET/CT) with68Ga-PSMA is a non-invasive diagnostic technique to image prostate cancer with increased prostate-specific membrane antigen (PSMA) expression. PSMA is a transmembrane protein present in all prostatic tissues. Increased PSMA expression is seen in several malignancies, although prostate cancer is the tumour where it presents higher concentrations. Almost all prostate adenocarcinomas show PSMA expression in most of lesions, primary and metastatic. Immunohistochemistry has demonstrated that the expression of PSMA increases in patients with de-differentiated, metastatic or hormone-refractory tumours. Moreover, the expression level of PSMA has a prognostic value for disease outcome. PET measures the three-dimensional distribution of68Ga-PSMA, producing semi-quantitative images that allow for non-invasive assessment of PSMA expression.
2018
García Garzón, J., de Arcocha Torres, M., Delgado-Bolton, R., Ceci, F., Alvarez Ruiz, S., Orcajo Rincón, J., et al. (2018). 68Ga-PSMA PET/CT in prostate cancer. REVISTA ESPAÑOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 37(2), 130-138 [10.1016/j.remn.2017.07.004].
García Garzón, J.R.*; de Arcocha Torres, M.; Delgado-Bolton, R.; Ceci, F.; Alvarez Ruiz, S.; Orcajo Rincón, J.; Caresia Aróztegui, A.P.; García Vellos...espandi
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/626389
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 30
  • ???jsp.display-item.citation.isi??? 29
social impact